Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation

References

• World Health OrganizationDiabetes. Fact sheet Number 31282011 Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.htmlAccessed January 15, 2012
   Google Scholar
• ShawJESicreeRAZimmetPZGlobal estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract201087141419896746
   PubMed Web of Science ®Google Scholar
• GilliesCLLambertPCAbramsKRDifferent strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysisBr Med J200833676541180118518426840
   PubMed Web of Science ®Google Scholar
• FeigDSPaldaVALipscombeLCanadian Task Force on Preventive Health CareScreening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health CareCMAJ2005172217718015655234
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in CanadaCanad J Diab200832 Suppl 1S14S17
   Google Scholar
• BadawiAKlipAHaddadPType 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional interventionDiabetes Metab Synd Obes20103173186
   PubMedGoogle Scholar
• HoergerTJHarrisRHicksKADonahueKSorensenSEngelgauMScreening for type 2 diabetes mellitus: a cost-effectiveness analysisAnn Intern Med2004140968969915126252
   PubMed Web of Science ®Google Scholar
• GoyderECIrwigLMScreening for type 2 diabetes mellitus: a decision analytic approachDiabet Med200017646947710975217
   PubMed Web of Science ®Google Scholar
• LiRZhangPBarkerLEChowdhuryFMZhangXCost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic reviewDiabetes Care20103381872189420668156
   PubMed Web of Science ®Google Scholar
• RaikouMMcGuireAThe economics of screening and treatment in type 2 diabetes mellitusPharmacoeconomics200321854356412751913
   PubMed Web of Science ®Google Scholar
• HoergerTJHicksKASorensenSWCost-effectiveness of screening for pre-diabetes among overweight and obeseDiabetes Res2007301128752879
   Google Scholar
• WilsonSERosellaLCLipscombeLLManuelDGThe effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort studyBMC Public Health201010150620727141
   PubMed Web of Science ®Google Scholar
• HuxJEIvisFFlintoftVBicaADiabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithmDiabetes Care200125351251611874939
   PubMed Web of Science ®Google Scholar
• PalmerAJRozeSValentineWJSpinasGAShawJEZimmetPZIntensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United KingdomClin Ther200426230432115038953
   PubMed Web of Science ®Google Scholar
• RasmussenSGlumerCSandbaekALauritzenTBorch-JohnsenKProgression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION study, DenmarkDiabetologia200650229329717143605
   PubMed Web of Science ®Google Scholar
• O’ReillyDHopkinsRBlackhouseGHuxJDolovichLDevelopment of an Ontario Diabetes Economic Model (ODEM) and Application to a Multidisciplinary Primary Care Diabetes Management ProgramReport Prepared for the Ontario Ministry of Health and Long-term Care2006
   Google Scholar
• HernanWHHoergerTJBrandleMDiabetes Prevention Program Research Group The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose toleranceAnn Intern Med2005142532333215738451
   PubMed Web of Science ®Google Scholar
• MeigsJMullerDNathanDBlakeDAndresRBaltimore Longitudinal StudyThe natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of agingDiabetes20035261475148412765960
   PubMed Web of Science ®Google Scholar
• BonoraEKiechlSWilleitJOberhollenzerFEggerGPopulation-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck studyDiabetes20045371782178915220202
   PubMed Web of Science ®Google Scholar
• DaviesMTringhamJJarvisJSkinnerTCFarooqiAMKhuntiKSystematic screening for type 2 diabetes mellitus: results of a large population based study targeting those with conventional risk factorsDiabet Med200522 Suppl 299
   Google Scholar
• ZhangYEngelgoanMValdezREfficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetesDiabetes Care20052861321132515920046
   PubMed Web of Science ®Google Scholar
• AvenellABroomJBrownTSystematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvementHealth Technol Assess2004821iiiiv1182
   PubMed Web of Science ®Google Scholar
• HernanWHBrandleMZhangPDiabetes Prevention Program Research GroupCosts associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention programDiabetes Care2003261364712502656
   PubMed Web of Science ®Google Scholar
• ClarkePGrayAHolmanREstimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)Med Decis Making200222434034912150599
   PubMed Web of Science ®Google Scholar
• WaughNScotlandGMcNameePScreening for type 2 diabetes: literature review and economic modellingHealth Technol Assess20071117iiiivixxi1125
   Web of Science ®Google Scholar
• TarrideJ-EHopkinsRBlackhouseGA review of methods used in long-term cost-effectiveness models of diabetes mellitus treatmentPharmacoeconomics201028425527720222752
   PubMed Web of Science ®Google Scholar
• ChatterjeeRNarayanKMVLipscombJPhillipsLSScreening adults for pre-diabetes and diabetes may be cost-savingDiabetes Care20103371484149020587721
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationImplications of the United Kingdom Prospective Diabetes StudyDiabetes Care200326 Suppl 1S28S3212502617
   PubMedGoogle Scholar
• SchauflerTMWolffMCost effectiveness of preventive screening for type-2-diabetes mellitus in GermanyAppl Health Econ Health Policy20108319120220408603
   PubMedGoogle Scholar